Updated:
Myrexis, Inc.
Myrexis, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001459450, and its reported industry is...
Overview
Myrexis, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001459450, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-07-17, it reported net income of USD -11,621,000; total assets of USD 1,237,000 for the fiscal period ended 2013-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Myrexis, Inc.
- Former names in filing history
- Myriad Pharmaceuticals, Inc. (2009-04-01 to 2010-06-18)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- New York, NY, United States
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 0001459450
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2013USD | -$11.6M | $1.2M | $1.1M | -$13.0M | |
| FY2012USD | -$31.2M | $91.7M | $19.7M | -$27.8M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-K/A | Form 10-K/A | ||
| 10-K | FORM 10-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | Form 8-K | ||
| 8-K | Form 8-K | ||
| DEF 14A | Form DEF 14A | ||
| SC 13D | — | Form SC 13D | |
| 8-K | Form 8-K | ||
| 8-K | Form 8-K | ||
| 8-K | Form 8-K | ||
| 8-K | Form 8-K | ||
| 10-Q | FORM 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Myrexis, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.